Status:

COMPLETED

The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)

Lead Sponsor:

Ministry of Health, Labour and Welfare, Japan

Collaborating Sponsors:

The National Institute of Biomedical Innovation

Conditions:

Coronary Disease

Cerebral Infarction

Eligibility:

All Genders

20+ years

Brief Summary

The purpose of this study is to determine the clinically meaningful definition and prevalence of aspirin resistance based on data linking aspirin-dependent laboratory tests to recurrent vascular event...

Detailed Description

Primary Outcomes: The primary endpoint is the composite outcomes of cerebral infarction, transient ischemic attack, myocardial infarction, unstable angina, percutaneous coronary angiography, thromboem...

Eligibility Criteria

Inclusion

  • Adult males or females who met the criteria listed below:
  • Patients who had acute coronary syndrome, cerebral infarction (except cardioembolic stroke), or transient ischemic attack between past 28 days and the past 2 years
  • patients who receive long-term aspirin therapy (at least 28 days)
  • Patients who are \>=20 years of age
  • Patients willing and able to give written informed consent

Exclusion

  • Malignancy or suspected malignancy
  • Patients who showed platelet counts less than 100,000/uL or more than 450,000/uL
  • Congenital bleeding tendency
  • Patients who receive other antiplatelet drugs or warfarin
  • Patients with atrial fibrillation
  • Patients who received surgical operation or catheter intervention within the past 2 weeks
  • Patients who received anticoagulation drug therapy including heparin ( low-molecular weight heparin) and danaparoid.
  • Patients with more than modified Rankin scale 4

Key Trial Info

Start Date :

November 1 2005

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

March 1 2011

Estimated Enrollment :

583 Patients enrolled

Trial Details

Trial ID

NCT00250380

Start Date

November 1 2005

End Date

March 1 2011

Last Update

December 13 2011

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

Research Institute for Brain and Blood Vessels Akita

Akita, Akita, Japan, 0100874

2

National Fukuoka-Higashi Medical Center

Koga, Fukuoka, Japan, 8113195

3

Hokkaido Neurosurgical Memorial Hospital

Sapporo, Hokkaido, Japan, 0600022

4

Nakamura Memorial Hospital

Sapporo, Hokkaido, Japan, 0600061